DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 140 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $185,396 | -14.7% | 13,454 | +2.3% | 0.00% | -50.0% |
Q1 2024 | $217,354 | +11.3% | 13,157 | -1.6% | 0.00% | +100.0% |
Q4 2023 | $195,246 | +28.7% | 13,373 | +8.2% | 0.00% | 0.0% |
Q3 2023 | $151,694 | +11.8% | 12,363 | +8.8% | 0.00% | 0.0% |
Q2 2023 | $135,734 | – | 11,368 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners XI LLC | 2,491,561 | $30,571,453 | 26.81% |
Atlas Venture Life Science Advisors, LLC | 7,608,394 | $93,354,994 | 14.46% |
DAFNA Capital Management LLC | 586,463 | $7,195,901 | 2.24% |
Nicholas Investment Partners, LP | 2,188,654 | $26,854,785 | 2.01% |
RA Capital Management | 7,809,852 | $95,826,884 | 1.89% |
BRAIDWELL LP | 3,715,573 | $45,590,081 | 1.44% |
PFM Health Sciences, LP | 2,224,598 | $27,295,817 | 1.29% |
SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $6,503,100 | 1.18% |
COMMODORE CAPITAL LP | 739,661 | $9,075,640 | 1.06% |
Parkman Healthcare Partners LLC | 466,408 | $5,722,826 | 1.05% |